Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
6
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 6 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Famotidine* Famotidine | D | $179M | -12% | 3,926,510 | $46 | $0.16 |
| Ibuprofen-Famotidine Ibuprofen/FAmotidine | D | $2.7M | -46% | 2,788 | $971 | $2.81 |
| Pepcid Famotidine | D | $795K | -5% | 191 | $4,160 | $18.83 |
| Duexis Ibuprofen/FAmotidine | D | $368K | -97% | 91 | $4,043 | $26.01 |
| Famotidine Famotidine/PF | D | $74K | +6% | 1,718 | $43 | $0.48 |
| Famotidine Famotidine In NaCl,Iso-Osm/PF | D | $663 | -22% | 56 | $12 | $0.16 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.